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Summary
Calcium modulating cyclophilin ligand (CAML) is a
ubiquitously expressed protein implicated in T cell
signaling, although its mechanism and physiologic
role in the immune system are unknown. We show
here that CAML is essential for peripheral T cell devel-
opment. Inactivation of CAML in mouse thymocytes
lowered the numbers of double-positive and single-
positive thymocytes, concomitant with reduced posi-
tive and enhanced negative selection. We found that
CAML interacts with p56Lck and appears to regulate
subcellular localization of the kinase in both resting
and T cell receptor (TCR)-stimulated cells. CAML-defi-
cient cells displayed enhanced p56lck and ZAP-70
phosphorylation and increased IL2 production and
cell death after TCR stimulation, suggesting that
CAML may act as a negative regulator of p56lck. Our
data establish a novel role for CAML as an essential
mediator of T cell survival during thymopoiesis and
indicate that its loss deregulates p56Lck signaling.
Introduction
T cells arise from bone marrow-derived precursors,
which migrate to the thymus where they undergo ex-
pansion, maturation, and selection. Thymocytes begin
as relatively undifferentiated cells, lacking most T cell-
specific surface markers, such as the coreceptors CD4
and CD8 and the signaling complex CD3, and not yet
having undergone T cell receptor (TCR) α or β gene
rearrangements. After an initial period of differentiation,
CD4−CD8− double negative (DN) cells initiate β-selec-
tion through their pre-TCRs followed by rapid prolifera-
tion before becoming CD4+CD8+ double positive (DP)
cells (Germain, 2002; Sebzda et al., 1999). Subsequently,
DP cells that receive intermediate levels of signals
through appropriate TCR subunits mature to CD4+ or
CD8+ single-positive (SP) cells. Thymocytes that fail to
receive antigen receptor signals die by neglect whereas
cells that receive strong TCR-mediated signals die as a
result of negative selection. Thus, the strength of TCR-
induced signals plays a critical role in the DP to SP
transition of thymocyte development and directs the fi-
nal outcomes in terms of cell differentiation, prolifera-
tion, survival, or programmed cell death.
After TCR engagement, the Src-family protein tyro-*Correspondence: bram.richard@mayo.edusine kinase (PTK) p56Lck is recruited to the TCR:CD3
complex through its interaction with the coreceptors
CD4 and CD8 (Weiss and Littman, 1994), where it phos-
phorylates the immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) of CD3ζ chains. Phosphorylated ζ
chains then recruit ZAP70 to the stimulated antigen
receptor, which in turn becomes activated as a result
of autophosphorylation and transphosphorylation by
p56Lck (Chan et al., 1995; Neumeister et al., 1995).
p56Lck is expressed and required during the early DN
stage of thymocyte development, as accumulation of
DP cells is markedly impaired in p56Lck knockout mice
(Molina et al., 1992) and plays an essential role in both
negative and positive selection processes (Trobridge et
al., 2001). Besides its maturation-promoting role, p56Lck
has been implicated in inducing thymic and T cell apo-
ptosis during negative selection and peripheral homeo-
stasis, respectively (Gonzales-Garcia et al., 1997; Tu-
osto et al., 2002). Tight regulation of p56Lck activity
during TCR-induced signaling is, therefore, essential
for maintaining a functional activation threshold distin-
guishing between cellular stimulation and death.
CAML is a ubiquitous integral membrane protein that
has been shown previously to be a resident of the en-
doplasmic reticulum (Bram and Crabtree, 1994; Hollo-
way and Bram, 1996, 1998). Overexpression of CAML
in Jurkat T cells led to constitutive activation of Ca2+-
dependent transcription, leading to the hypothesis that
it may modulate receptor or signaling function in lym-
phocytes. CAML was subsequently identified as an in-
tracellular binding partner for the B-lymphocyte-spe-
cific tumor necrosis factor receptor family member
TACI (von Bulow and Bram, 1997) and was postulated
to function in TACI-induced signaling. To test for a role
in T cell function, we recently completed the generation
of a CAML knockout mouse (Tran et al., 2003); however,
the early lethality found in CAML null embryos made
such a determination impossible. To bypass this lethal-
ity, we have generated conditional CAML knockout
mice and induced excision of the gene specifically in
thymocytes. We report here that CAML plays an essen-
tial role in thymocyte development. We also describe a
novel physical interaction between CAML and p56Lck,
which appears to critically regulate the threshold of thy-
mocyte activation.
Results
Creation of Conditional CAML Knockout
Mice in Thymocytes
We generated conditional knockout mice by using a
Cre-lox system (Kuhn et al., 1995) in which the CAML
gene was selectively disrupted in thymocytes. Mice
bearing a floxed CAML allele (CAMLfl) were mated with
mice carrying a cre transgene under the control of the
lck proximal promoter (lck-cre), which is first active in
DN thymocytes and is inactivated in the periphery (Chi
et al., 2003) (see Figure S1 in the Supplemental Data
available with this article online). CAMLfl/− mice were
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140viable, indicating that the introduction of lox-P sites did t
enot disrupt the function of the CAML locus. CAMLfl/−
lck-cre+/− mice (designated tCAML−/−) were normal in W
cappearance and size in comparison to the control. Thy-
mus size was decreased but morphology appeared t
tnormal upon dissection of tCAML−/− animals.
We determined the efficiency with which tCAML−/− t
pthymocytes excised the floxed CAML allele by immu-
noblotting whole-cell lysates from total thymocytes or o
hpurified CD4+CD8+ DP cells. Cre-mediated gene exci-
sion depleted CAML protein by greater than 95% in h
fcells from tCAML−/− mice (Figure S1C), and there was
no evidence for a smaller N-terminal truncation product t
bof the Cre-mediated CAML gene. Excision efficiency
was low (<50%) in a small number (30%) of mice, as
assessed by immunoblotting. Sporadic low-efficiency P
gene excision in lck-cre mice has been observed by S
others (Schmidt-Supprian et al., 2003). Therefore, for T
CAMLfl/− lck-cre+/− mice used in the experiments be- b
low, the efficiency of CAML gene excision was verified s
by immunoblotting and mice that did not demonstrate o
greater than 95% loss of CAML protein were not used c
in data analyses. f
p
Reduced Numbers of DP and SP Thymocytes w
in tCAML−/− Mice q
Overall, the average numbers of total thymocytes were (
reduced by half in tCAML−/− mice (mean of 1.8 × 108/ T
thymus in 3- to 4-week-old mice) compared to litter- t
mate control animals (mean of 0.78 × 108/thymus) (Fig- t
ure 1A). The number of cells at the DN stage was not m
different in mutant mice (Figures 1B and 1C). This was l
not unexpected, as DN cells contained normal CAML t
protein levels (Figure 1G, lanes 3 and 4). CAML gene C
deletion and protein depletion were essentially com- m
plete at the DP stage (Figure 1G, lanes 5 and 6), and b
this was accompanied by a 50% reduction in cell num- s
bers (Figure 1D). tCAML−/− mice consistently had 4- to C
6-fold fewer CD4 and CD8 SP cells as compared to i
littermate controls (Figures 1B, 1E, and 1F). Given the u
low number of SP thymocytes in tCAML−/− mice, it was
possible that CAML protein was absolutely required for w
DP to SP conversion, with a minor population of non- O
gene-excised cells making up the residual SP popula- d
tions. However, CD4 SP thymocytes in tCAML−/− mice a
lacked CAML protein, indicating that a small fraction of b
CAML-deficient DP cells were indeed able to mature to a
the SP stage (Figure 1G, lanes 7 and 8). D
p
3Thymocytes Lacking CAML Do Not Contribute
to the Peripheral T Cell Subset s
sWe next asked whether CAML-deficient SP thymocytes
could complete development to the peripheral T cell l
mstage. In young tCAML−/− mice (3–4 weeks), there were
7- to 9-fold fewer peripheral CD4+ and CD8+ T cells in a
mcomparison to littermate controls; however, in older
mice (8–9 weeks), T cell numbers in tCAML−/− and con- v
ptrol mice were more similar to each other (Figure 1I).
We suspected that the residual T cells in the periphery t
Dof young tCAML−/− mice might represent those that es-
caped Cre-mediated excision in the thymus and were C
nthus able to complete normal development and expand
to repopulate the periphery in older animals. (Note that whe proximal-lck-promoter-driven cre transgene is only
xpressed in early thymocytes.) This was verified by
estern analyses of total lysates from CD3+ spleno-
ytes. The few peripheral T cells in 3- to 4-week-old
CAML−/− mice contained normal levels of CAML pro-
ein compared to controls (Figure 1H), consistent with
his prediction. Further analysis with a quantitative
olymerase chain reaction (PCR) assay revealed that
nly about 9% of peripheral T cells in 3-week-old mice
ad undergone excision of the CAMLfl allele, in spite of
ighly efficient deletion (>97%) observed in thymocytes
rom the same animals (data not shown). We conclude
hat CAML is required for mice to develop normal num-
ers of peripheral T cells.
ositive Selection Is Impaired, Whereas Negative
election Is Enhanced in tCAML−/− Thymocytes
CR activation regulates thymocyte development at
oth the DP and SP stages, and components of the
ignaling cascade are required for normal production
f T cells (Starr et al., 2003). TCR-activated DP thymo-
ytes inducibly express CD69 and upregulate TCRβ
rom intermediate to high levels. At the completion of
ositive selection, SP cells express high levels of TCRβ
hile they gradually downregulate CD69 and become
uiescent in preparation for export into the periphery
Gabor et al., 1997). We observed a decrease in
CRβ-high, CD69-positive cells in the DP subset from
CAML−/− mice (Figure 2A), a picture noted by others
o suggest a defect in positive selection. Furthermore,
utant CD8 SP cells actually had substantially higher
evels of CD69 and decreased TCRβ compared to con-
rols (Figure 2B). A similar trend was also observed with
D4 SP cells (Figure 2C), suggesting that tCAML−/− thy-
ocytes not only may have defective positive selection
ut they also appear to remain activated in the SP
tage. Coincident with these observations, tCAML−/−
D4 SP cells underwent apoptosis at greater rates
n vivo, as judged by Annexin V and PI staining (Fig-
re 2D).
To examine positive selection, we used OT1 mice,
hich express a transgenic TCR specific for a chicken
VA peptide. Thymic CD8 SP cells undergo enrichment
ue to positive selection in OT1 Kb mice (Hogquist et
l., 1994). tCAML−/− OT1 mice displayed reduced num-
ers of total thymocytes and lower proportions of DP
nd SP cells (Figure 3A). All thymocytes, including the
N cells, demonstrated the expected high-level ex-
ression of the transgenic TCR α2, β5 chains (Figure
B). The defect in CD8 SP cell production was also
een in the peripheral T cell population (data not
hown). Further confirmation of a defect in positive se-
ection in the absence of CAML was obtained by using
ice expressing the transgenic DO11 TCR specific for
class II-restricted chicken OVA peptide. Like OT1
ice, tCAML−/− mice bearing the DO11 transgene re-
ealed a severe reduction of all thymocyte subsets, es-
ecially the DP and CD4 SP cells as compared to con-
rol (Figure 3C). Peripheral CD4 T cells from tCAML−/−
O11 mice were reduced in number and expressed
AML protein, as revealed by western blotting (data
ot shown). Thus, enforced positive selection not only
as insufficient to overcome the defect in CAML-defi-
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141Figure 1. Thymocyte Development Is Compromised in the Absence of CAML
(A and C–F) Relative numbers of different thymocyte subsets per thymus from littermate-control and tCAML−/− mice (n = 28; *p < 0.01;
**p < 10−8).
(B) Representative FACS plots of thymocyte subsets from tCAML−/− and littermate-control mice.
(G) CAML immunoblots of lysates from total (left) and subsets of thymocytes (right) in littermate-control and tCAML−/− mice reveal efficient
CAML protein depletion in DP and CD4 SP cells. Equal loading was assessed by actin immunoblotting.
(H) CAML-deficient thymocytes do not contribute to the peripheral T cell repertoire. CAML immunoblots of whole-cell lysates (WCLs) from
CD3+ splenocytes in 3-week-old mice show that the majority (>80–90%) of peripheral T cells in tCAML−/− animals are CAML positive.
(I) 3- to 4-week-old mice had 7- to 9-fold reduced numbers of peripheral T cells, which approached normal levels in older mice (8- to 9-week
old) (n = 14; *p < 10−5)
Error bars represent standard deviations.
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142Figure 2. Phenotypic Analyses of tCAML−/− Thymocytes
(A–C) FACS analyses of viable DP (A), CD8 SP (B), and CD4 SP (C) thymocytes from tCAML−/− and littermate-control mice for CD69 and TCRβ
are shown. The percentage of cells staining positive for individual markers is indicated above the gate. Mean and median of fluorescence
intensity are given for all cells.
(D) Relative percentage of CD4 SP cells that are Annexin V-positive and PI-negative between littermate-control and tCAML−/− mice (n = 12;
*p = 0.00002). Error bars represent standard deviations.cient mice but also appeared to make the defect in the a
aDP-SP transition more pronounced (Figures 1 and 3).
We next asked if CAML is required for normal nega- t
ttive selection. We used tCAML−/− mice bearing the
H-Y TCR that strongly recognizes a male-specific anti- p
2gen and causes negative selection of thymocytes in
male mice (Kisielow et al., 1988). Analysis of thymocyte t
Cmaturation from male mice bearing the H-Y transgene
showed a significant decrease in the CD8 SP compart- d
ment in the absence of CAML (Figure 3D). In addition,n in vitro assay of negative selection was performed,
s described by others (Doerfler et al., 2000), by using
hymocytes from OT1, tCAML−/− mice. We incubated
otal thymocytes with antigen-presenting cells in the
resence of increasing amounts of OVA peptide 257–
64. In this model, DP cells are induced to die by nega-
ive selection due to strong signaling through the TCR.
AML-deficient OT1 cells underwent peptide-depen-
ent cell death more readily than cells from littermatecontrol OT1 mice, when exposed to intermediate OVA
Regulation of Thymocyte Development by CAML
143Figure 3. CAML Is Required for Normal Thymocyte Selection
(A) Representative FACS analyses of thymocyte populations in OT1 tCAML−/− mice (right) and littermate OT1 controls (left). Total thymocyte
counts were 75 million (left) and 14.4 million (right).
(B) All OT1 tCAML−/− thymocytes had appropriate expression levels of Vβ5 and Vα2 of the transgenic TCR.
(C) Counts of the different thymocyte subsets in DO11 tCAML−/− and littermate DO11 controls. Error bars represent standard deviations.
(D) Representative FACS plots of total thymocytes from male H-Y tCAML−/− (bottom) and littermate male H-Y controls (top).
(E) In vitro negative selection assay. Treated DP cells were quantitated by FACS, and the percent remaining (compared to maximal number)
was plotted. Representative results of two independent experiments are shown.peptide concentrations (EC50 of 10 pM versus 100 pM
peptide concentration, respectively) (Figure 3E), sug-
gesting that CAML deficiency favors enhanced nega-
tive selection.
We conclude from these analyses that CAML is re-
quired for thymocyte development. The primary fea-
tures of its knockout phenotype include increased
negative selection at the expense of positive selection
and prolonged activation and apoptosis at the SPstage, combining to result in a failure to contribute to
the peripheral T cell compartment.
CAML-Deficient Thymocytes Undergo Increased
Cell Death upon TCR Ligation
We next sought to delineate the mechanism underlying
defective selection and production of peripheral T cells
in tCAML−/− mice. Given the exquisite sensitivity of thy-
mocyte death to TCR-dependent signaling, it was pos-
Immunity
144sible that CAML might serve to modulate signals that s
tactivate thymocytes and their selection in the thymus.
Alternatively, CAML might simply provide a constitutive
fsurvival function required by thymocytes in order to
cmature. To discern between these possibilities, we
aexamined the mechanism of increased apoptosis in
stCAML−/− thymocytes by performing in vitro activation
sassays. This procedure recapitulates many features of
psignaling-dependent thymic maturation, including de-
ppendence upon appropriate levels of TCR as well as
ecostimulatory receptor signaling (McKean et al., 2001).
cIn this system, low CD28 costimulation drives matura-
ttion of TCR-stimulated DP thymocytes to CD4 SP cells
mwhereas high CD28 costimulation activates apoptosis.
wDP thymocytes, purified from mutant and control
lmice, were stimulated by crosslinking the TCR and
aCD28 with monoclonal antibodies, and the resulting
rates of activation, maturation, and apoptosis were de-
ttermined. Low-level stimulation (low concentration of
oTCR-antibody only) induced relatively normal activation
(of CD69 in CAML knockout thymocytes (Figures 4A and
a4C, left). However, the percentage of live activated DP
gthymocytes (CD69-positive, Annexin V-negative, and
sPI-negative) decreased 2-fold when maximally acti-
tvated (treatment with 1 g/ml anti-TCR + 30 g/ml anti-
ICD28) (Figure 4A upper left quadrants, and 4C, left), not
sunlike the in vivo findings (Figure 2A).
tWithout CD28 crosslinking, TCR-stimulated tCAML−/−
(DP cells underwent more apoptosis than did control
ccells (Figure 4A, upper right quadrants). With the addi-
ation of CD28 costimulation, significantly more cell
ddeath occurred, as indicated by the increased percen-
stage of Annexin V-positive cells (Figure 4A). tCAML−/−
tthymocytes exhibited slightly higher percentages of
mactivated cells (CD69-positive, including both live and
wdying cells) when suboptimally activated (Figure 4C,
sright). This coincided with a substantial increase in cell
Sdeath under all stimulation conditions (Figure 4D). In
oline with these observations, the absolute counts of live
unactivated cells (CD69-negative, Annexin V-negative,
rand PI-negative) remaining after coengagement of TCR
cand CD28 were 2- to 3-fold lower in the tCAML−/− cul-
otures compared to the controls, indicating that CAML-
d
deficient DP cells die rather than undergo maturation.
(
This calculation was performed by multiplying the per-
o
centages of each (16.5% and 27.2%, respectively, for y
control and tCAML−/−cultures, Figure 4A, TCR + CD28, t
left lower quadrant) by the absolute numbers of PI- c
negative cells remaining in each culture (0.73 × 106 ver- F
sus 0.19 × 106 for control and tCAML−/− cultures, re- w
spectively). This suggested, therefore, that the lower b
numbers of live activated cells (CD69-positive, Annexin w
V-negative) from tCAML−/− mice both in vivo (Figure 2A) e
and in vitro at the higher level of CD28 crosslinking (Fig- c
ures 4A and 4C) were most consistent with increased p
apoptosis induced by TCR stimulation in tCAML−/− k
cells rather than due to deficient signal strength. o
In vitro maturation of DP into CD4 SP cells did occur d
but was substantially depressed (2- to 4-fold lower) in
tCAML−/− DP cells (Figure 4B), as demonstrated by the o
reduced appearance of SP cells after stimulation and f
recovery. This effect recapitulated the in vivo findings n
kand likely reflected increased cell death at the CD4 SPtage, although we cannot rule out a partial contribu-
ion of CAML to the maturation process itself.
We next examined the time course of cell death as a
unction of activation in CAML-deficient cells. Thymo-
ytes were stimulated with high levels of TCR and CD28
ntibodies and examined for induction of CD69 and on-
et of apoptosis at 4, 12, and 24 hr. At all time points,
timulated CAML-deficient cells demonstrated a higher
ercentage of apoptosis in the activated fraction (CD69-
ositive) compared to control cells (Figure 4E). In these
xperiments, survival of unactivated CAML-deficient
ells was similar to control cells (see Figure 4A, “Un-
reated,” upper right quadrant, for example). Further-
ore, the enhanced cell death in CAML-deficient cells
as restricted to those that developed reduced surface
evels of CD4 and CD8, which is a characteristic event
fter activation of DP thymocytes (Figure 4F).
We suspect that CAML does not function as a consti-
utive survival factor, because increased apoptosis was
bserved only in the activated fraction of tCAML−/− DP
Figures 4E and 4F) and not in those cultured in the
bsence of stimulation (Figure 4A, “Untreated”). The
reater degree of activation-dependent apoptosis in-
tead raised the possibility that CAML might regulate
hymocyte maturation by modulating TCR signal strength.
L-2 is produced by T cells that are activated through
uboptimal stimulation of both the TCR and a corecep-
or such as CD28, but not in the absence of either one
Weiss and Littman, 1994). In the thymus, SP thymo-
ytes are the only cells capable of producing IL-2 when
ctivated (data not shown). We therefore assessed the
egree of activation of SP cells upon antigen receptor
timulation by measuring TCR-induced IL-2 produc-
ion. Thymocytes from tCAML−/− and littermate-control
ice, normalized to contain equal numbers of SP cells,
ere cultured for 30 hr with varied levels of receptor
timulation, and IL-2 secretion was determined. tCAML−/−
P thymocytes produced significantly increased amounts
f IL-2, even under suboptimal activation conditions (1
g/ml anti-TCR with or without 3 g/ml anti-CD28) that
esulted in no detectable IL-2 production by control SP
ells (Figure 5A, left). Moreover, at intermediate levels
f anti-CD28 crosslinking (10 g/ml antibody), CAML-
eficient SP thymocytes generated 3-fold more IL-2
Figure 5A, left) than did control cells. With higher levels
f coreceptor ligation (30 g/ml anti-CD28), the IL-2
ield by control SP thymocytes surpassed that of
CAML−/− cells (Figure 5A, left), perhaps due to the in-
reased cell death in the knockout cultures (as seen in
igure 4D). Increased IL-2 production by tCAML−/− cells
as not due to greater numbers of total thymocytes
eing added to the culture, because similar results
ere also obtained when we repeated the assay with
qual numbers of total thymocytes from tCAML−/− or
ontrol mice, irrespective of the 2- to 3-fold lower SP
opulation in tCAML−/− thymuses (Figure 5A, right). Jur-
at T cells stably expressing a dominant-negative form
f CAML demonstrate hyperactivity and enhanced cell
eath upon TCR activation.
To independently verify the effect of CAML deficiency
n activation-induced apoptosis of thymocytes in a dif-
erent system, we tested stable expression of a domi-
ant negative (DN) form of CAML (CAML1-189) in Jur-
at T cells (Zhao et al., 1997). This N-terminal fragment
Regulation of Thymocyte Development by CAML
145Figure 4. tCAML−/− DP Thymocytes Demonstrate Enhanced Programmed Cell Death and Defective Maturation In Vitro
(A and B) FACS plots of Day-1 stimulation (A) and Day-2 recovery (B) cultures of littermate-control and tCAML−/− thymocytes. “TCR” antibody
was used at 1 g/ml and “CD28” antibody at 30 g/ml. Total numbers of PI-negative cells remaining after overnight stimulation are as follows:
control (untreated, 1.01 × 106; TCR, 9.8 × 105; TCR + CD28, 7.3 × 105); tCAML−/− (untreated, 1.1 × 106; TCR, 7.0 × 105; TCR + CD28, 1.9 × 105).
(C) Plots of live CD69-positive, Annexin V-negative (left), and all live (PI-negative) CD69-positive cells (right) expressed as a percent of total
PI-negative thymocytes. At low levels of CD28 costimulation, tCAML−/− thymocytes become apoptotic more readily than control cells and
have higher CD69 levels (right). Error bars represent standard deviations.
(D) Higher death rates in tCAML−/− DP cells. The numbers of PI-positive cells in experiments similar to (A), expressed as a percent of total
thymocytes, are plotted. Death rates in untreated cells were subtracted out as background. Error bars represent standard deviations.
(E) Time course of appearance of viable CD69-positive cells (Annexin V-negative) and apoptotic CD69-positive cells in unstimulated cultures
(“NS”) and TCR+CD28-stimulated cultures (“S”). The indicated phenotypes are expressed as a percentage of total thymocytes at 4, 12, or 24
hr as noted. Error bars represent standard deviations.
(F) Activation dependence of cell death in tCAML−/− cells. Thymocytes stimulated in vitro for 6 hr with TCR+CD28 antibodies were stained
for CD4, CD8, Annexin V, and PI. Dying or dead cells (as indicated) were predominantly in the CD4lowCD8low population. CD4highCD8high cells
(representing unactivated thymocytes) did not display enhanced death.
Representative data from at least 2 independent experiments are shown.
Immunity
146Figure 5. Thymocytes Lacking CAML or Jur-
kat T Cells Expressing a Dominant-Negative
Form of CAML Produce More IL-2 While Un-
dergoing Higher Rates of Apoptosis
(A) Representative plots of IL-2 production
by thymocytes from littermate-control and
tCAML−/− mice. Total thymocytes normalized
to contain equal numbers of SP cells (left) or
equal absolute numbers of total thymocytes
(right) were treated as indicated for 30 hr.
IL-2 production in untreated cells was less
than 1.7 U/ml and was subtracted out as
background. Error bars represent standard
deviations.
(B) A representative plot of IL-2 production
by Jurkat T cells with either GFP or DN-
CAML and treated as indicated for 24 hr in
the absence of serum. IL-2 production in un-
treated cells was less than 6 U/ml and was
subtracted out as background. Error bars
represent standard deviations.
(C and D) Jurkat cells expressing DN-CAML
had increased apoptotic rates as measured
by surface binding to Annexin V (C) or by up-
take of PI (D) upon treatment with OKT3 for
48 hr in the absence of serum. Values for un-
treated cells were less than 10% and were
subtracted out as background.of CAML was previously shown to bind to protein part- t
iners of the full-length protein (including the EGF recep-
tor [EGFR] and TACI receptor) and to interfere with TACI W
Csignaling and EGFR recycling (Tran et al., 2003; von Bu-
low and Bram, 1997). A plasmid directing enforced ex- c
apression of the DN-CAML mutant fused to the green
fluorescent protein (GFP) was stably transfected into i
LJurkat cells. Pools of transfected cells were enriched
by sorting with GFP. In comparison to control cells ex- m
apressing GFP alone, DN-CAML protein caused a quali-
tatively similar increase in IL-2 production (Figure 5B), T
(apoptosis (Figure 5C), and cell death (Figure 5D) after
TCR stimulation with antibody. To rule out the possi- 1
dbility that this enhanced apoptosis was due to in-
creased IL-2 production by cells bearing the DN-CAML p
agene, we repeated the experiment in the presence of
excess exogenous IL-2 and observed similar results t
t(data not shown). Taken together, these data suggest
that CAML negatively modulates TCR-induced activa-
ction threshold to prevent excessive T cell activation and
subsequent apoptosis. W
a
tCAML Interacts with p56Lck in an Activation-
aDependent Manner
CAML was recently found to interact directly with the p
ttyrosine kinase domain of the EGFR to regulate its in-racellular trafficking during its recycling phase, thereby
nfluencing EGF-induced proliferation (Tran et al., 2003).
e were therefore interested in determining whether
AML might similarly interact with a T lymphocyte-spe-
ific PTK. p56Lck is the first PTK to be recruited to the
ctivated TCR-CD3 complex, where it initiates a signal-
ng cascade resulting in T cell activation (Weiss and
ittman, 1994) and plays a critical role in T cell develop-
ent (Molina et al., 1992). Moreover, modulating p56Lck
ctivation was shown to have a profound impact on
CR signal strength leading to either thymic maturation
Sohn et al., 2001) or apoptosis (Gonzales-Garcia et al.,
997; Tuosto et al., 2002). Most importantly, the recent
iscovery that the recycling endosomal pool of inactive
56Lck was translocated to the immunological synapse
fter TCR stimulation (Ehrlich et al., 2002) inspired us
o examine endogenous CAML and p56Lck for a poten-
ial interaction.
CAML was immunoprecipitated from Jurkat whole-
ell lysates, and associated proteins were detected by
estern blotting analysis. p56Lck was found to specific-
lly coprecipitate with CAML in resting cells (Figure 6A,
op). The reverse experiment with p56Lck monoclonal
ntibodies for immunoprecipitation again revealed the
resence of a p56Lck-CAML complex (Figure 6A, bot-
om). Similar results were obtained with lysates from
Regulation of Thymocyte Development by CAML
147Figure 6. CAML Interacts with the Kinase Domain of p56Lck
(A) Immunoprecipitation (IP) of 1.5 mg of whole-cell lysate (WCL) proteins from Jurkat T cells with anti-CAML polyclonal antibodies (pAb)
(top) or anti-p56Lck monoclonal antibodies (mAb) (bottom) or isotype-matched control antibodies; immunoblotting (IB) was done with anti-
p56Lck mAb (top) or anti-CAML pAb (bottom). Abbreviations: Rab. IgG, rabbit preimmune immunoglobulin G.
(B) Immunoprecipitation of 0.5 mg of WCLs from normal thymocytes by using anti-CAML pAb as in (A). Immunoblotting was done with
indicated monoclonal antibodies.
(C and D) CAML does not bind LAT (C) or p59Fyn (D).
(E) Immunoprecipitation of 1.5 mg of WCLs from OKT3-treated Jurkat T cells using anti-CAML pAb; immunoblotting was done with indicated
antibodies, showing that the CAML-p56Lck interaction is maximal in resting cells. The arrowheads denote the p56 and p59 forms of Lck. Note
that CAML interacts only with the p56 species that is not phosphorylated at Y394. Both short (1 min) and long (20 min) exposures of the
same film showed no association. WCLs demonstrate activation of p56Lck.
(F) Immunoprecipitation of 0.5 mg of WCLs from Jurkat cells treated with OKT3 for 1 min, by using anti-pY394 p56Lck; immunoblotting was
done with indicated antibodies, confirming the absence of a CAML-pY394 p56Lck interaction. Immunoblotting of WCLs before and after pY394
immunoprecipitation indicated that pY394 p56Lck was quantitatively recovered in this experiment.
(G) Immunoprecipitation of 1.5 mg of WCLs from OKT3-treated Jurkat T cells by using anti-p56Lck mAb or control antibodies shows a similar
trend in the CAML-p56Lck interaction upon TCR stimulation as in (E). Immunoblotting was done with indicated pAb.
(H–I) The kinase domain of p56Lck is required for the CAML-p56Lck interaction. (H, top) Immunoprecipitation of endogenous CAML from
lysates of 293T cells transiently expressing fusion proteins of GFP and Lck mutants with a C-terminal flag tag by using anti-CAML pAb.
Immunoblotting was done with the M2 mAb. (Bottom) An immunoblot of the same WCLs verified the expression of each mutant. (I) Diagrams
of the Lck mutants used in (H) and a summary of their CAML binding properties in vivo are shown. Abbreviations: U, unique domain; SH2-3,
Src-homology domain 2 and 3; R, regulatory domain.
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148normal mouse thymocytes (Figure 6B). This interaction v
pwas specific, as CAML did not associate with LAT (Fig-
ure 6C), an adapter protein localized at the TCR (Zhang c
ret al., 1998) in either resting or TCR-activated cells.
Also, there was no evidence of interaction between e
sCAML and p59Fyn (Figure 6D).
Previous studies demonstrated that the single most
pabundant 56 kD form of Lck in quiescent cells changes
after TCR activation to a more slowly migrating species t
cof 59 kDa (Stefanova et al., 2003), representing the
multiply phosphorylated kinase. One of the first phos- s
pphorylation events of p56Lck occurs at the tyrosine resi-
due 394 (Y394) within the activation loop, which is criti- a
(cally required for the initial activation of the kinase and
does not cause changes in mobility (Alonso et al., 2004). p
pCAML-associated Lck corresponded to the faster-mov-
ing species of 56 kDa (Figures 6E, 6F, and 6G) and was p
onot phosphorylated at Y394, indicating the complex in-
volves the inactive form of the kinase. (
1We next asked whether the p56Lck kinase domain
was required for its association with CAML, similar to 7
rthe previously described EGFR-CAML interaction. De-
letion mutants of p56Lck (residues 1–62, 1–119, 1–209, v
cand 232–509) were constructed, expressed in 293T
cells, and tested for coimmunoprecipitation with CAML. s
sAlthough full-length p56Lck (c’-509) and the kinase do-
main alone (232–509) transiently expressed in this fash- t
nion specifically interacted with endogenous CAML, mu-
tants (c’-62, c’-119, and c’-209) lacking sequences o
Tspanning the kinase domain failed to associate (Figures
6H and 6I). Thus, the CAML-p56Lck interaction requires a
tsequences within the kinase domain.
t
nCAML Negatively Regulates p56Lck Activation
tAlthough some p56Lck localizes to the plasma mem-
Zbrane through its N-terminal myristyl group, a large por-
Ction of the protein is retained in intracellular recycling
iendosomes and is subsequently translocated to TCR:
nCD3 complexes upon activation (Ehrlich et al., 2002).
aThe finding of a complex containing both CAML and
othe resting p56Lck, which appears to decline after TCR
wactivation (Figure 6), raised the possibility that CAML
pmight regulate T cell stimulation directly by modulating
kthe subcellular localization or temporal activation of
fp56Lck. Therefore, we performed subcellular fraction-
ration of endogenous p56Lck in Jurkat T cells with or
lwithout the DN-CAML protein, to separate cells into cy-
atosolic and membrane fractions (Cao et al., 2002). In
pcontrol Jurkat T cells, total cellular p56Lck was evenly
divided between these two fractions, whereas in the
tpresence of the DN-CAML, localization of p56Lck in the
tdigitonin-insoluble fraction was disrupted (Figure 7A),
Tsuggesting that CAML may be required for targeting
tp56Lck to cellular membranes. We next examined the
location and movement of the resting and activated ki-
nase in these cells. As opposed to a central concentra- D
tion in resting normal cells, endogenous p56Lck revealed
more scattered distribution in cells lacking functional C
HCAML (Figure 7B, top), which was associated with an
enhanced activation of the kinase as measured by p
gstaining for Y394 phosphorylation (Figure 7B, bottom).
The improper localization of p56Lck in the absence of c
mnormal CAML was further exacerbated after TCR acti-ation, showing a disorderly dispersal and diminished
lasma membrane clustering when compared to the
ontrol cells (Figure 7B). These data suggest that CAML
egulates proper distribution of p56Lck, possibly influ-
ncing the appropriate function of the kinase in re-
ponse to TCR stimulation.
A link between CAML and membrane localization of
56Lck provides a potential mechanism for the hyperac-
ive phenotype of cells lacking functional CAML. To
onfirm that p56Lck is indeed hyperactive in the ab-
ence of CAML, we measured TCR-dependent phos-
horylation of p56Lck on residue Y394. In both resting
nd TCR-stimulated Jurkat cells expressing DN-CAML
Figure 7C) and in tCAML−/− thymocytes (Figure 7E),
56Lck was more highly phosphorylated at Y394 com-
ared to controls. We verified the hyperactivity of
56Lck function by measuring TCR-induced activation
f ZAP70, an immediate downstream target of p56Lck
Chan et al., 1995, Pelosi et al., 1999, Di Bartolo et al.,
999). Analogous to the p56Lck activation profile, ZAP-
0 phosphorylation on Y319 was significantly higher in
esting tCAML−/− thymocytes and remained more ele-
ated 15 to 30 min after stimulation, in comparison to
ontrol (Figure 7F). DN-CAML also caused qualitatively
imilar changes in Jurkat cells (Figure 7D), resulting in
ubstantially enhanced phosphorylation of ZAP70 at all
ime points of TCR ligation. This effect was accompa-
ied by a more rapid degradation of ZAP70 after 5 min
f treatment, consistent with its known response to
CR activation (Penna et al., 1999). We suspect that
ugmented ZAP70 activation in the absence of func-
ional CAML is due to increased activity of p56Lck rather
han to a direct effect of CAML on ZAP70, as coimmu-
oprecipitation experiments did not reveal the exis-
ence of a physical interaction between CAML and
AP70 (data not shown). To rule out the possibility that
AML prevents excessive p56Lck activation by directly
nhibiting the activity of the kinase, we performed a ki-
ase assay with recombinant active p56Lck and enolase
s a substrate in the presence of high concentrations
f recombinant GST-CAML1-189 or control GST. There
as no evidence of decreased p56Lck activity in the
resence of the recombinant CAML1-189, whereas the
inase was efficiently inhibited by PP2, a specific src-
amily kinase inhibitor (data not shown). We cannot cur-
ently rule out the possibility, however, that the full-
ength CAML protein might directly block p56Lck kinase
ctivity, because it is insoluble and could not be pre-
ared in recombinant form for this assay.
Taken together, these results suggest that CAML in-
eracts with p56Lck to regulate its subcellular localiza-
ion and timely activation of the kinase in response to
CR induction, thus perhaps leading to positive selec-
ion and survival of DP and SP thymocytes.
iscussion
AML Is Required for T Cell Development
ere, we establish a requirement for CAML in T lym-
hocyte development through its specific gene tar-
eting in murine thymocytes. CAML gene deletion
aused a significant reduction in thymocyte numbers,
ost notably at the SP stage, and a nearly complete
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149Figure 7. CAML Is Required for p56Lck Membrane Localization and Negatively Regulates p56Lck Activation
(A) Immunoblot of cytosolic and membrane fractions of Jurkat T cells expressing GFP or DN-CAML by using indicated antibodies shows that
p56Lck localization requires functional CAML.
(B) Immunostaining of resting and OKT3-treated Jurkat T cells for total endogenous p56Lck (top) and phospho-Y394 p56Lck (bottom).
(C–E) Hyperactivation of p56Lck in the absence of functional CAML. Immunoblots of WCLs from TCR-stimulated control Jurkat cells or those
expressing the DN-CAML (C, top) and tCAML−/− and littermate control thymocytes (E, top) by using indicated antibodies. “p-Lck” indicates
p56Lck phosphorylated at Y394. The ratio of p-p56Lck over total p56Lck was plotted (C and E, bottom).
(D–F) Chronic activation of ZAP70 in the absence of functional CAML is shown. Immunoblots of WCLs from TCR-stimulated control or DN-
CAML-expressing Jurkat cells (D, top) and tCAML−/− and littermate-control thymocytes (F) by using indicated antibodies. “p-ZAP70” indicates
ZAP70 phosphorylated at Y319. The ratio of p-ZAP70 over total ZAP70 was plotted (D and F, bottom).loss of T cells in the periphery. In vitro studies indicated
that tCAML−/− thymocytes were more susceptible to
apoptosis after their activation via TCR-stimulation. On
the other hand, apoptosis in unstimulated cells (an indi-
cator of “death-by-neglect”) was not increased in
CAML-deficient cells, thus it is not likely that CAML
controls a stimulus-independent regulator of apoptosis.
Consistent with these findings, we observed increasedrates of apoptosis during selection of DP cells and at
the SP stage. However, there was not evidence for a
complete block at the DP to SP transition in the context
of a wild-type TCR pool, because the residual CD4 SP
thymocytes in tCAML−/− mice demonstrated the high
efficiency of CAML gene deletion seen at the DP stage.
A closer look at the role of CAML in thymic selection
by using tCAML−/− mice bearing either the OT1, DO11
Immunity
150or HY TCR transgenes as well as an in vitro negative s
lselection assay revealed that positive selection was
nearly abolished with evidence of substantially enhanced r
cnegative selection. These findings indicate that CAML
may regulate TCR signal strength such that in its absence t
ta positive-selecting signal is shifted from the positive to
the negative pathway, whereas a negative-selecting sig- t
cnal is intensified. Alternatively, it is possible that CAML
may regulate the duration of TCR-dependent signaling C
tthrough a Lck-dependent feedback loop. We currently do
not have evidence to distinguish between these two p
models; however, we did not observe significant differ-
ences in Lck-activation at 30 or 60 minutes after TCR d
(stimulation between CAML-knockout and control thymo-
cytes (data not shown), thus, further studies will be re- n
tquired to establish this possibility.
Given the paucity of peripheral T cells in young mice, l
sit does not seem likely that an inability to compete with
normal mature T cells is the explanation for the CAML m
Bdependency in T cell production. In addition, the lower
number of SP populations within the thymus indicates r
lthat the absence of CAML-deficient peripheral T cells
is not solely due to a defect in egress. Instead, our data p
tshowed that increased apoptosis during selection con-
tinues on to the SP stage as most of these cells remain m
Iactivated as suggested by their heightened CD69 ex-
pression. The lack of CAML-deficient T cells in the pe- s
priphery of tCAML−/− mice of all ages is thus consistent
with an additional defect in this late phase of T cell l
odevelopment and lends further support to the notion
that CAML functions to prevent excessive activation C
pand programmed cell death.
Apoptotic cells are removed very rapidly in vivo by A
cthymic macrophages, thus making it difficult to deter-
mine their phenotype (i.e. activated or quiescent) at the t
utime of death. The suggestion from the in vitro studies
was that loss of CAML may lower the activation thresh- l
pold, leading to the observed consistent increase in re-
sponse to minimal stimuli, resulting in increased CD69 n
land IL-2 expression as well as higher degrees of stimu-
lation-induced apoptosis. In either case, the in vitro ac- r
Jtivation studies suggested that CAML is not, in fact,
required for T cell activation events but rather is essen- i
ttial to block excessive stimulation and cell death after
engagement of TCR and CD28. The in vitro maturation h
pof CAML-deficient DP cells to CD4 SP cells was less
efficient than that of wild-type controls, which may rep- s
Cresent either a true block in developmental progression
or may simply be a result of enhanced death after acti- p
cvation in these mutant cells, or both. This novel role for
CAML was not predicted from the original observation T
aof enhanced Ca2+ influx signaling in cells seen with the
transient-transfection method. The conditional knock-
out technique, therefore, provides a valuable means to s
critically evaluate the true function of the gene, thus r
avoiding potential complications associated with high- m
level expression studies. l
a
pCAML Interacts with p56Lck and Is a Negative
mRegulator of Its Functions
tBecause our prior work in embryonic stem cells iden-
tified a specific binding activity of CAML for the tyro- iine kinase domain of the EGFR through which it regu-
ates the recycling property of the receptor, it seemed
easonable to search for a similar PTK candidate in T
ells. Indeed, we did observe a specific interaction be-
ween CAML and p56Lck in Jurkat T cells and native
hymocytes. This newly discovered interaction appears
o require the kinase domain of inactive p56Lck, reminis-
ent of the EGFR interaction with CAML. However,
AML does not bind indiscriminately to kinases, as
here was no significant interaction found with either
59Fyn or ZAP-70.
The kinetics of the CAML-p56Lck interaction appear
istinct from those of the CAML-EGFR association
Tran et al., 2003) and may reflect the differences in the
atural cellular distributions of the two kinases. Unlike
he EGFR being principally a cell surface receptor, a
arge fraction of p56Lck is present at recycling endo-
omes in resting cells that translocate to the plasma
embrane after TCR stimulation (Ehrlich et al., 2002).
ecause CAML was previously found to modulate the
ecycling of internalized EGFR, it is possible that it simi-
arly participates in the translocation of intracellular
56Lck to the immunologic synapse. Consistent with
his view, the CAML-inactive p56Lck association was
aximal in resting cells and declined after TCR ligation.
t appears that p56Lck is released from an intracellular
tore and becomes activated and translocated to the
lasma membrane after TCR stimulation. This regu-
ated sequence of events was disrupted in the absence
f functional CAML. We favor the hypothesis that
AML is required for both the integrity of the internal
ool of p56Lck and its delivery to the plasma membrane.
lthough p56Lck can leave the internal store and be-
ome activated in cells expressing the dominant-nega-
ive CAML, it does so even in the absence of TCR stim-
lation and fails to show efficient membrane
ocalization with or without activation. Although the
recise consequences of this trafficking disruption are
ot entirely clear, it is evident that loss of CAML did
ead to inappropriate activation of the kinase. In either
esting or TCR-stimulated tCAML−/− thymocytes and
urkat T cells expressing DN-CAML, both p56Lck and
ts substrate ZAP-70 exhibited enhanced phosphoryla-
ion. In line with hyperactivation of p56Lck, these cells
ad significantly increased IL-2 production, CD69 ex-
ression, and concomitant apoptosis, especially under
uboptimal stimulating conditions. We propose that
AML functions to maintain the proper storage of
56Lck to prevent excessive activation and to ensure
arefully measured release of the kinase in response to
CR stimulation, thereby facilitating productive T cell
ctivation with less cell death.
DP thymocytes enter a complex process of stringent
election based on the binding affinity of their antigen
eceptors to the self-MHC:peptide complexes (Ger-
ain, 2002). Such activation thresholds are tightly regu-
ated in the decision-making process during selection,
lthough the underlying mechanisms are not com-
letely understood. To that end, our findings that CAML
odulates the intracellular trafficking of p56Lck and its
imely activation provide novel mechanistic insights
nto the regulation of TCR signaling during the pro-
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151cesses of thymocyte selection as well as T cell func-
tions.
Experimental Procedures
Generation of CAML Conditional Knockout Mice in T Cells
129/SvJ ES cells were electroporated with the targeting plasmid,
and 125 G418-resistant clones were screened by Southern blotting
and PCR to obtain 16 targeted recombinants. Five recombinants
were transiently transfected with the Cre recombinase expression
vector pMC-Cre, and 210 ganciclovir-insensitive clones were
screened by PCR to obtain eight correctly Cre-excised recombi-
nants. Five recombinants were injected into blastocysts to produce
chimeric mice, which were crossed to produce flox heterozygotes
(CAMLfl/+). These mice were then crossed with CAML+/− lck-cre+/−
mice to obtain CAM fl/− lck-cre+/− mice, designated as tCAML−/−.
Immunoprecipitation and Western Blotting Analysis
Cells were lysed on ice (1% Triton X-100, 20 mM HEPES [pH 7.4],
5 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM Iodoace-
tamide, 100 M Na2VO4, 1 mM PMSF, 10 g/ml leupeptin, and 45
g/ml aprotinin). One to two milligrams of lysates was precipitated
with 10 g of antigen-specific antibodies or appropriate control
antibodies (Pharmingen). Western blots were probed for Fyn, Lck
(Santa Cruz), pY319-ZAP70 and pY394-Lck (pY416-src) (Cell Sig-
naling), actin (Sigma), ZAP70, CAML, or LAT. Affinity-purified rabbit
polyclonal antiserum raised against the N-terminal residues 1–189
of CAML was used for precipitation or blotting of murine CAML.
Thymocyte Stimulation and Recovery Assay
Performed as previously described (McKean et al., 2001). Briefly,
total thymocytes were panned twice by using anti-CD8 antibodies
(mAb 83-12-5). This purification procedure consistently produced
thymocyte preparations that were > 94% DP cells. 2.5 × 106 puri-
fied DP cells were then cultured for 18 hr (day 1 culture) in 24-
well plates precoated with the indicated combinations of anti-TCRβ
(H57) and anti-CD28 (mAb 37.51, Pharmingen), and cellular activa-
tion and apoptosis were measured with PE-anti-CD69, FITC-
Annexin V, and PI (Pharmingen). The rest of the stimulated cells
were transferred to recovery plates without antibodies for an addi-
tional 24 hr (day 2) and assayed for CD4 and CD8 expression.
IL-2 Bioassay
Performed as previously described (Ruegemer et al., 1990). Briefly,
Jurkat T cells or total thymocytes were cultured for 24 hr or 30 hr
in 24-well plates precoated with different amounts of OKT3 or anti-
TCRβ and anti-CD28 antibodies, respectively. Supernatants were
cultured in triplicates for 24 hr with 10,000 HT-2 cells, an IL-2-
dependent cell line. 10 Ci of [3H]-thymidine (Amersham) per well
was added during the last 6 hr of treatment, and incorporated
counts were determined. The amount of IL-2 produced was deter-
mined against a standard curve by using recombinant IL-2 (Sigma).
Supplemental Data
Supplemental Data including one figure are available online with
this article at http://www.immunity.com/cgi/content/full/23/2/139/
DC1/.
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